Israeli bio-tech Oramed has announced that its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints. The Phase 2b study will be carried out later this year, and Oramed plans a Phase 2a study for Type 1 diabetes.
http://www.globes.co.il/en/article-oramed-reports-success-in-oral-insulin-study-1000913524